Why partner with devintec Out-Licensing?
Creating value together
30% + turnover invested in 2019
Invested in Research & Development
Currently approved and marketed products in several disease areas (Gastroenterology, allergology, gynecology and dermatology)
20+ scientific research based projects and a prospective global expansion
We continue to discover and develop our technology in new disease areas
Where our products are approved and marketed that certify their quality and innovativeness.
Continuous improvement and R&D investment
Medical and scientific support
Regulatory support for registration
Working ethically and accountably
Gain access to novel solutions & speed up time-to-market
Synergy with current portfolio
Sales & Marketing engine
Focused & Driven